Annotation Detail for NAGPA
Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of NAGPA mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of NAGPA mRNA | affects expression | 17562736
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.91 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.39 | 18445737 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
2.99 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.99 | 3084413 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.83 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
3.09 | 6135515 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.78 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.08 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
4.08 | 19420014 11529661 19923254 11461765 19370779 15968718 2444490 12705907 16485898 16227642 15619225 17906064 10663392 10915739 17562736 11287661 10774834 14986274 12392966 11834606 19164858 16177239 12153990 14725611 16081117 12958197 12594235 17522070 18713872 14550746 16393943 19085960 16109766 18071297 11739529 12540782 11743745 19416960 11421492 16781746 19739265 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
5.17 | 19426721 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.74 | 16983495 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
3.11 | 16870215 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.44 | 12587719 15629191 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.41 | 16705839 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.71 | 19460945 11587558 19014921 16611625 12969438 16610002 19784758 12587719 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.74 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.29 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.82 | 2876784 2876786 6135515 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
4.33 | 19513568 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.75 | 7678174 18551238 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.31 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.94 | 16049721 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.82 | 16870215 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.85 | 18551238 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.43 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
5.20 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.58 | 10982225 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00141 |
- |
N-Acetyl-D-glucosamine |
Dietary supplement;Micronutrient |